Series B

A new oral drug candidate for lupus and RA emerges as Totus Medicines uses its AI platform to rapidly develop a first-in-class inhibitor for the elusive IRF5 protein.

A luxury brand and an NGO award women in bio-tech and MedTech, tackling the stark funding gap and championing a new generation of impact-driven founders.

The deal accelerates Sanas's infrastructure-first strategy, adding key tech and a serial entrepreneur to rewire how real-time speech AI operates at scale.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

A high-level visit to General Atomics signals a major U.S. push for fusion energy, blending private innovation with public funding to win a global race.

After a massive reverse stock split and a tumultuous offering, Linkers Industries finalizes its capital overhaul. Is this a strategic reset or a crisis averted?

A new partnership combines local infrastructure with global expertise, aiming to streamline development for startups and solidify Singapore's biotech leadership.

Five new clinical trials in Chicago repurpose existing drugs for PTSD, cancer, and more, offering a faster, cheaper path to treating unsolved diseases.

Brands are disappearing from new AI search engines. A new discipline called 'Machine Relations' aims to solve this 'AI invisibility' crisis.

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

Finnish defense firm Sensofusion buys aircraft maker Atol Aviation, shifting counter-drone warfare from the ground to the sky in a major strategic leap.

With FDA clearance, Zeto New Wave™ promises to slash EEG wait times and ease staff shortages, making critical brain health data more accessible.

With a key data readout looming for its chronic cough drug, Nocion adds a renowned dealmaker to its board, fueling speculation of a potential acquisition.

After 11 straight quarters of growth, clean nail care pioneer MiniLuxe lands new funding. Discover how its tech-driven, ethical model is winning.

With its lead drug for a rare pediatric liver disease entering late-stage trials, NorthSea Therapeutics adds a veteran drug developer to its board.

New research shows parents welcome corporate sponsors in schools to fill funding gaps, creating a powerful new marketing channel built on community trust.

Fueled by a $250K grant from Allen Family Philanthropies, a new pilot aims to tackle Seattle's infamous social isolation with a structured national plan.

Growth equity firm SEMCAP launches a new fund with Unilever Prestige visionary Vasiliki Petrou, targeting the booming wellness and longevity market.

Pixee Medical's AR glasses are challenging costly robots, offering surgeons a new, highly accurate, and efficient way to perform knee replacements.

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.